Highlights

Partners of TIDO

Over the years, Boston Children's has developed relationships with pharmaceutical, biotechnology, medical device, drug discovery and diagnostic companies to develop and launch products based on Boston Children's innovations. Boston Children's also works with venture capital and angel investors, nonprofit organizations, disease foundations, government agencies and contract research organizations (CRO's) to establish collaborations and relationships at all stages of innovation and development (e.g. research and development, pre-clinical and clinical testing) to increase the translation of our world-class, cutting edge research into new therapies, drugs, vaccines, diagnostics and devices. Below is a listing of commercialization partners that have collaborated with Boston Children's.

Organization

PI

Description

Venture Capital Organizations
ARCH Venture Partners Leonard Zon Part of a team of investors who formed Fate Therapeutics, with Dr. Len Zon as a scientific founder, developing a new approach to stem cell medicine.
Atlas Venture M. Judah Folkman Funded Zafgen, a company focused on the use of anti-angiogenic agents for regulating new blood vessel formation to prevent the growth of adipose tissue--and thereby provide a treatment to reduce obesity.
Polaris Ventures Leonard Zon Part of a team of investors who formed Fate Therapeutics, with Dr. Len Zon as a scientific founder, developing a new approach to stem cell medicine.
Scheer & Company Anthony Atala Formed Tengion Inc. around Tony Atala's portfolio of tissue engineered organs.
Companies started by VCs
Fate Therapeutics Leonard Zon Created in 2007 with Dr. Len Zon as a scientific founder, developing therapeutics to promote stem cell therapy.
Zafgen M. Judah Folkman The world's first biotechnology company focused on the treatment of obesity through the direct targeting of adipose vasculature to safely reduce the size of fat tissue.
Non-Profit Funding Sources
Center for Integration of Medicine and Innovative Technology (CIMIT) Funded multiple Boston Children's Hospital investigators for minimally invasive technologies.
Harvard Stem Cell Institute (HSCI) Boston Children's Stem Cell Program; Leonard Zon, Director; George Daley, Associate Director Led by its Executive Committee (including from Boston Children's Stem Cell program, Leonard Zon, Chair, and George Daley), the HSCI provides early stage seed grant funding, targeted disease program project grants, and research core facility support in the field of stem cell research; the HSCI supports the embryonic stem cell core facility at Boston Children's Hospital, serving Boston Children's Hospital and the Harvard community. To date, 15 Boston Children's Hospital researchers have received HSCI research grants.
Massachusetts Technology Transfer Center State funding and grants for selected Boston Children's Hospital technology development projects, professional conferences and host the Massachusetts online technology postings site.
National Institute of Health (NIH)/Department of Defense (DoD)/Small Business Innovation Research (SBIR) program Joseph Madsen, Eugene Goldfield Provide funding for early stage and prototype development of novel biomedical devices.
PATH/Genocea Biosciences Richard Malley Funding to develop a pneumococcal vaccine.
Company Collaborators and Sponsors
Charles River Laboratories N/A Storage of Proteins and Cell Lines.
Fisher Clinical Services N/A Storage of Proteins and Cell Lines.
Idera Pharmaceuticals Ofer Levy Sponsored research in the area of toll like receptor agonists.
Infoscitex Corporation (IST) Joseph Madsen, Eugene Goldfield Collaboration with IST for the development of a number of medical device prototypes
Microfabrica Pedro del Nido Collaboration with Boston University and Microfabrica to develop miniature tools at the end of steerable needles for use in intracardiac surgery.
Optimum Technologies, Inc. Farhad Imam Several prototypes developed for Dr. Imam's transluminal catheter.
Philips Healthcare Pedro del Nido Collaboration with Harvard University, Boston University and Philips Healthcare to develop ultrasound imaging intracardiac beating heart surgery.
QinetiQ North America/Foster-Miller, Inc. (FMI) Joseph Madsen, Eugene Goldfield Collaboration with FMI for the development of a number of medical device prototypes
Symmetry Medical TNCO Pedro del Nido Worked to develop a prototype of a video-assisted cardioscopy port for beating heart intracardiac surgery.
Symmetry Medical TNCO Martha Murray Worked to develop a prototype for delivering a proprietary tissue repair material to the meniscus in the knee. The device was designed for minimally-invasive procedures to facilitate healing within the body.

Boston Children's Hospital has licensed to the following representative companies:

Children's HospitalTerms and Conditions
Site Designed and Developed by Genuine